Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment

Abroad (travel likely)RecruitingPHASE3

Conditions

Severe Hemophilia A

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Feng Xue)
  • Fuyang Hospital, Affiliated to Anhui Medical University, Fuyang, China

    Contact: Study coordinator (Qingyi Wang)
  • Fujian Medical University Union Hospital, Fuzhou, China

    Contact: Study coordinator (Meijuan Huang)
  • Ganzhou People's Hospital, Ganzhou, China

    Contact: Study coordinator (Jingdong Zhang)
  • Nanfang Hospital of Southern Medical University, Guangzhou, China

    Contact: Study coordinator (Jing Sun)
  • Anhui Provincial Hospital, Hefei, China

    Contact: Study coordinator (Xiaoyu Zhu)
  • Huai'an Second People's Hospital, Huai'an, China

    Contact: Study coordinator (Yanming Zhang)
  • Jinan central hospital, Jinan, China

    Contact: Study coordinator (Yun Chen)
  • The Second Affiliated Hospital of Kunming Medical University, Kunming, China

    Contact: Study coordinator (Zeping Zhou)
  • The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    Contact: Study coordinator (Peng Cheng)
  • Affiliated Hospital of Nantong University, Nantong, China

    Contact: Study coordinator (Li Yang)
  • The First Affiliated Hospital of Nanyang Medical College, Nanyang, China

    Contact: Study coordinator (Huibing Dang)
  • Qinghai Provincial People's Hospital, Qinghai, China

    Contact: Study coordinator (Wenqian Li)
  • Rizhao People's Hospital, Rizhao, China

    Contact: Study coordinator (Jing Li)
  • The Second Hospital of Hebei Medical University, Shijiazhuang, China

    Contact: Study coordinator (Jingyu Zhang)
  • The Second Hospital of Shanxi Medical University, Taiyuan, China

    Contact: Study coordinator (Zhuanzhen Zheng)
  • North China University of Science and Technology Affiliated Hospital, Tangshan, China

    Contact: Study coordinator (Zhenyu Yan)
  • Wenzhou People's Hospital, Wenzhou, China

    Contact: Study coordinator (Miaoyong Zhu)
  • Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology., Wuhan, China

    Contact: Study coordinator (Huafang Wang)
  • Affiliated Hospital of Jiangnan University, Wuxi, China

    Contact: Study coordinator (Haiying Hua)
  • Xi'an Central Hospital, Xi'an, China

    Contact: Study coordinator (Yanping Song)
  • Subei People's Hospital of Jiangsu province, Yangzhou, China

    Contact: Study coordinator (Mei Sun)
  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Hu Zhou)
  • Zhengzhou People's Hospital, Zhengzhou, China

    Contact: Study coordinator (Shuxia Guo)
Study leads
  • Renchi Yang, PhD

    Study Chair

    Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.